About Molecular Vision
Molecular Vision is a Healthcare company based in London (United Kingdom) founded in 2001, and was acquired by Abingdon Health in March 2012. Optical detection platforms for portable medical diagnostics are developed. The company has 1 employees. The company was acqui-hired. Its focus areas include Life Sciences, Ophthalmology and In-Vitro Diagnostic Tests. Its legal entity is MOLECULAR VISION LIMITED.
Company details
Molecular Vision was founded in 2001 in London, United Kingdom, as a spin-out from Imperial College London. An optical detection platform using organic light emitting diodes and organic photodetectors was developed for quantitative analysis in portable, disposable formats. Patent-protected technology supports low-cost medical diagnostics for point-of-care markets, enabling tests for multiple disease markers on single devices. Acquisition by Abingdon Health occurred in January 2015.
- Headquarters London, United Kingdom
- Employees 1
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website molecularvision.co.uk
- Social LinkedIn
- Acquired by Abingdon Health (Mar 2012)
- Legal Name Molecular Vision Limited
- Date of Incorporation 24 Sep, 2001
- Jurisdiction YORK, ENGLAND
- Net Profit-$230.5 K (USD)as on Dec 31, 2020
- Investors
- Employee Count1
- Acquired byAbingdon Health
(Mar 2012)
Investors in Molecular Vision
Molecular Vision has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Abingdon Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Developer of immunoassays for diagnostic purposes | 2008 | abingdonhealth.com | York, United Kingdom |
Investor details for Molecular Vision
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Molecular Vision
2 dated milestones of Molecular Vision across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Molecular Vision is founded.
- Exit Acquired by Abingdon Health.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Molecular Vision
Molecular Vision was founded in 2001.
Molecular Vision is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Molecular Vision has 1 employees.
Molecular Vision was founded in 2001 in London, United Kingdom, as a spin-out from Imperial College London. An optical detection platform using organic light emitting diodes and organic photodetectors was developed for quantitative analysis in portable, disposable formats. Patent-protected technology supports low-cost medical diagnostics for point-of-care markets, enabling tests for multiple disease markers on single devices. Acquisition by Abingdon Health occurred in January 2015.
Molecular Vision has 1 investor. Key investors include Abingdon Health.
Molecular Vision operates through Molecular Vision Limited.
Yes. Molecular Vision was acquired by Abingdon Health in March 2012.